L-type amino acid transporter-1 overexpression and melphalan sensitivity in Barrett's adenocarcinoma. - Wikidata - wikimedia - TriplyDB

L-type amino acid transporter-1 overexpression and melphalan sensitivity in Barrett's adenocarcinoma.

L-type amino acid transporter-1 overexpression and melphalan sensitivity in Barrett's adenocarcinoma.

http://www.wikidata.org/entity/Q34787881

about

A review of the past, present, and future directions of neoplasia Coming of Age in the Life of Neoplasia: Where We Have Been and Where We Are Going Non-physiological amino acid (NPAA) therapy targeting brain phenylalanine reduction: pilot studies in PAHENU2 mice Potential Biomarker of L-type Amino Acid Transporter 1 in Breast Cancer Progression.Characterization of 2-(methylamino)alkanoic acid capacity to restrict blood-brain phenylalanine transport in Pah enu2 mice: preliminary findings.Update information on drug metabolism systems--2009, part II: summary of information on the effects of diseases and environmental factors on human cytochrome P450 (CYP) enzymes and transporters.Overexpression of SLC38A1 is associated with poorer prognosis in Chinese patients with gastric cancer.Dietary methionine can sustain cytosolic redox homeostasis in the mouse liver.Expression of L-type amino acid transporter 1 (LAT1) as a prognostic and therapeutic indicator in multiple myeloma Drug metabolism and clearance system in tumor cells of patients with multiple myeloma Novel harmine derivatives for tumor targeted therapy.Contribution of tumoral and host solute carriers to clinical drug response.Non-natural amino acids for tumor imaging using positron emission tomography and single photon emission computed tomography.Quantification of tryptophan transport and metabolism in lung tumors using PET.Positive Regulation of Decidualization by l-Type Amino Acid Transporter 1 (lat1) in Pregnant Mice Targeting L-type amino acid transporter 1 for anticancer therapy: clinical impact from diagnostics to therapeutics.shRNA-mediated Slc38a1 silencing inhibits migration, but not invasiveness of human pancreatic cancer cells.Antitumor effectiveness and mechanism of action of Ru(II)/amino acid/diphosphine complexes in the peritoneal carcinomatosis progression.Imaging melphalan therapy response in preclinical extramedullary myeloma with 18F-FDOPA and 18F-FDG PET.Comparative Proteomics Analysis of Barrett Metaplasia and Esophageal Adenocarcinoma Using Two-dimensional Liquid Mass Mapping

P2860

Q28389391-8BFDA32B-97EE-4D52-B191-E5028CCB685C Q28389985-33DF9B26-F116-4358-BF0B-6C03219E0840 Q28395095-3F496136-1F03-4868-BC5D-5CBAB5D8563D Q28703649-63AA4836-2EF1-4EAC-BA9A-67EFB12558E4 Q33704472-913A1382-10A9-42C9-86C7-FA7083BBB41A Q33829216-79EBE388-BF09-4329-96F4-5CC0D344665E Q34204238-0A75CC76-5430-483E-8AB6-A476CFECE42A Q35142411-327B2449-731C-4AC1-A7E1-58F888171E15 Q35206449-91344277-A910-42C3-8F47-529F47E08459 Q35713446-DA140759-B1E7-42EA-8AE2-011C176E1418 Q35742560-58885CDC-9269-43D9-A212-8C7CEAB211DA Q35832280-F1223B0F-2360-4701-B7F2-C62DD02580B2 Q35946876-3FBB7CC9-AC1B-4510-8AF3-F1DA76C274D3 Q37224527-8E75609F-58FF-48CA-B4B0-CC9F4366E471 Q37445396-6C4698C2-4D0F-43E6-8A4D-0E2C1003A856 Q37463275-C7C0D096-FE1C-4BAF-9AD1-E484CB068268 Q38476583-94ABF5FD-C2E4-493A-8BA7-07615F1944F9 Q42906650-7330EAE7-40D6-478E-9F25-5F48C4D0EDE9 Q50092474-29522538-65C2-44FD-B89C-8B7D3DA8D442 Q52716405-DCE40432-3925-4EFE-89FB-90D413861E48 Q58053810-0ADF632B-C850-484E-9C0E-7DDDE0E3159B

P2860

L-type amino acid transporter-1 overexpression and melphalan sensitivity in Barrett's adenocarcinoma.

http://www.wikidata.org/entity/Q34787881

description

2004 nî lūn-bûn

@nan

2004 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2004 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2004年の論文

@ja

2004年論文

@yue

2004年論文

@zh-hant

2004年論文

@zh-hk

2004年論文

@zh-mo

2004年論文

@zh-tw

2004年论文

@wuu

name

L-type amino acid transporter- ...... y in Barrett's adenocarcinoma.

@ast

L-type amino acid transporter- ...... y in Barrett's adenocarcinoma.

@en

L-type amino acid transporter- ...... y in Barrett's adenocarcinoma.

@nl

type

label

L-type amino acid transporter- ...... y in Barrett's adenocarcinoma.

@ast

L-type amino acid transporter- ...... y in Barrett's adenocarcinoma.

@en

L-type amino acid transporter- ...... y in Barrett's adenocarcinoma.

@nl

prefLabel

L-type amino acid transporter- ...... y in Barrett's adenocarcinoma.

@ast

L-type amino acid transporter- ...... y in Barrett's adenocarcinoma.

@en

L-type amino acid transporter- ...... y in Barrett's adenocarcinoma.

@nl

P1433

Q34787881-42ECC048-8E88-4D8D-A260-A0E08D56D1AD

P1476

Q34787881-1CF011C9-CB12-483D-8171-01683972F467

P2093

Q34787881-27B9213F-BDEF-4245-A301-9B2EC3B910EB

Q34787881-4569D610-C001-49D1-9B6E-1AA199810B05

Q34787881-4C0E3136-40B3-4BC8-984C-506AF884396A

Q34787881-4C2735C6-3553-4800-AC77-1B84F1C72E5C

Q34787881-54EA8444-57A7-45B9-984F-B0103A3F3EF7

Q34787881-7AF8CBED-343A-44A8-B89E-10E88A4C73E2

Q34787881-92C8DF04-5B56-4105-ADC2-99EE6E93C305

Q34787881-A501AED7-17BC-476D-A16B-1636A00DDDCF

Q34787881-A8C99017-060C-4F28-B2DE-2287F838EA30

Q34787881-FEC772A0-13AE-45D2-AD3A-AD9526421ACE

P2860

Q34787881-082A3B55-2758-4DB8-A860-798214DC6A92

Q34787881-083DDC8F-324B-4E0A-9E0C-70B438A3B039

Q34787881-1613D921-013B-4C21-A7EB-E36A0C76DC89

Q34787881-170932CE-9529-45BA-A8E1-19F760B7D13C

Q34787881-1B5C8D94-2D18-4A03-A709-DBAA704D2513

Q34787881-1F5DAD0C-6A8A-4002-8A17-D78CBEC85AEC

Q34787881-28215BD4-E35F-417D-9BF2-CB2CBBB657A9

Q34787881-2868FB29-E947-496D-86F6-95A43D2A109C

Q34787881-2F8F6485-73F3-4C04-9B99-B2B7F440E1D3

Q34787881-3170282F-6E5A-497B-B45C-3AB0CC8E779E

P304

Q34787881-691BA06E-4630-46BA-BD2E-0FC892867FDA

P31

Q34787881-EE850228-DBB2-458B-BB60-BECE4A030788

P356

Q34787881-8754D0EE-5A76-4998-AE16-EC1B9098E537

P433

Q34787881-DE8CAD7C-274E-429E-8F12-21DE50FC4137

P478

Q34787881-B88F9356-FEB8-4BBB-82F9-FC86BF8BDD6E

P577

Q34787881-2209975D-B326-4AA2-A032-18A5427071C0

P5875

Q34787881-CB56D504-7B4C-4022-83FD-116C194FD3E4

P698

Q34787881-06196823-508F-47DB-9E35-C1DF4823BB3F

P921

Q34787881-9FA94DED-38BA-4008-911D-EE5B72068C75

Q34787881-D5BE8B88-EE0D-40CD-BA9C-98ED340E01B1

P932

Q34787881-4EF6B8F3-9553-4D7C-9840-A98DAB630E52

P356

S1476-5586(04)80054-X

P1433

P1476

L-type amino acid transporter- ...... y in Barrett's adenocarcinoma.

@en

P2093

Christopher T Bauer

http://www.w3.org/2001/XMLSchema#string

Dafydd G Thomas

http://www.w3.org/2001/XMLSchema#string

David G Beer

http://www.w3.org/2001/XMLSchema#string

Duna A Raoof

http://www.w3.org/2001/XMLSchema#string

Gregory S Robinson

http://www.w3.org/2001/XMLSchema#string

Joel K Greenson

http://www.w3.org/2001/XMLSchema#string

Jules Lin

http://www.w3.org/2001/XMLSchema#string

Mark B Orringer

http://www.w3.org/2001/XMLSchema#string

Maureen J Bourner

http://www.w3.org/2001/XMLSchema#string

Thomas J Giordano

http://www.w3.org/2001/XMLSchema#string

P2860

Amino-acid transport by heterodimers of 4F2hc/CD98 and members of a permease family

Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method

Characterization of antigen recognized by the monoclonal antibody (4F2): different molecular forms on human T and B lymphoblastoid cell lines

Characterization of a monoclonal antibody (4F2) that binds to human monocytes and to a subset of activated lymphocytes

Decreased melphalan accumulation in a human breast cancer cell line selected for resistance to melphalan

Expression cloning and characterization of a transporter for large neutral amino acids activated by the heavy chain of 4F2 antigen (CD98)

Tissue microarrays for high-throughput molecular profiling of tumor specimens

Human LAT1, a subunit of system L amino acid transporter: molecular cloning and transport function.

Discordant protein and mRNA expression in lung adenocarcinomas.

L-DOPA transport properties in an immortalised cell line of rat capillary cerebral endothelial cells, RBE 4.

P304

74-84

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/S1476-5586(04)80054-X

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

6

http://www.w3.org/2001/XMLSchema#string

P577

2004-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

8632359

http://www.w3.org/2001/XMLSchema#string

P698

15068672

http://www.w3.org/2001/XMLSchema#string

P921

P932

1508631

http://www.w3.org/2001/XMLSchema#string